Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on Nasdaq Stockholm First North (ticker: DMYD B).
We now hope to be able to enhance the effect by combining the diabetes vaccine Diamyd® with other substances
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
Diamyd Medical faces an exciting future where the focus is on developing a new drug for autoimmune diabetes. Autoimmune diabetes, which includes type 1 diabetes and LADA, is characterized by the body’s...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the autoimmune...
rss icon
    
pdf icon
01 april 2015, 08:30
Delårsrapport II 14/15
Senaste Årsredovisningen
pdf icon
06 november 2014, 14:30
Årsredovisning 13/14